ORIAHNN (COPACKAGED) FDA approval date

The FDA approved ORIAHNN (COPACKAGED) on 29 May 2020.

FDA approval date
29 May 2020

Drug identity has not yet been verified against registry records

Also recorded as ELAGOLIX SODIUM; ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-05-29DayORIAHNN (COPACKAGED)FDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA213388", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["ORIAHNN (COPACKAGED)"], "active_ingredients": ["ELAGOLIX SODIUM", "ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200529", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026